Dr. Mark Talamonti: Surgical Advancements in Pancreatic Cancer
Onc Live
Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.
Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.
However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.
Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.
However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
Mark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer.
Currently, the state of the art is that there are a few institutions and a few high-volume surgeons who are able to perform laparoscopic or robotic pancreaticoduodenectomy procedures with the technical efficiency to favorably compare with open pancreatic surgery. Today, the gold standard remains as an open pancreaticoduodenectomy for patients with localized cancer in the head of the pancreas.
However, Talamonti believes that the technology will continue to evolve, training programs will become more formalized, and more surgeons will be able to - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
ark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer. - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
ark S. Talamonti, MD, clinical professor, NorthShore University HealthSystem, discusses some of the recent surgical advancements in pancreatic cancer. - See more at: http://www.onclive.com/conference-coverage/gi-2017/dr-talamonti-on-surgical-advancements-in-pancreatic-cancer#sthash.KhHWsBcx.dpuf
Dr. Mark Talamonti discusses recent surgical advancements in pancreatic cancer...Talamonti believes technology will evolve...and more surgeons will have the ability to...